TipRanks
Regenicin Inc (RGIN)
OTHER OTC:RGIN
US Market
RGIN
Regenicin
RESEARCH TOOLSreports

Regenicin (RGIN) Income Statement

4 Followers

Regenicin Income Statement

Last quarter (Q2 2023), Regenicin's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Regenicin's net income was $-336.44K. See Regenicin’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 22Sep 21Sep 20Sep 19Sep 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -601.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 601.18K$ 635.86K$ 510.82K$ 736.55K$ 789.11K
Depreciation and Amortization
$ 1.82K$ 635.86K$ 206.30K$ 171.86K$ 161.14K
EBITDA
$ -601.00K$ -636.00K$ -511.00K$ -737.00K$ -789.00K
Operating Income
$ -601.00K$ -635.86K$ -511.00K$ -737.00K$ -540.00K
Other Income/Expenses
$ -38.08K$ -34.74K$ -48.77K$ -21.90K$ -18.78K
Pretax Income
$ -639.00K$ -671.00K$ -560.00K$ -758.00K$ -559.00K
Net Income
$ -639.00K$ -670.60K$ -560.00K$ -758.00K$ -559.00K
Per Share Metrics
Basic EPS
$ 0.00$ >-0.01$ 0.00$ -0.01$ >-0.01
Diluted EPS
$ 0.00$ >-0.01$ 0.00$ -0.01$ >-0.01
Weighted Average Shares Outstanding
 153.48M 153.48M 153.48M 153.48M 153.48M
Weighted Average Shares Outstanding (Diluted)
 153.48M 153.48M 153.48M 153.48M 153.48M
Currency in USD

Regenicin Earnings and Revenue History